High expression of HOXA5 is associated with poor prognosis in acute myeloid leukemia

Juliusson, 2016, Leukemia, Prog Tumor Res., 43, 87, 10.1159/000447076 Shallis, 2019, Epidemiology of acute myeloid leukemia: recent progress and enduring challenges, Blood Rev, 36, 70, 10.1016/j.blre.2019.04.005 Abelson, 2018, Prediction of acute myeloid leukaemia risk in healthy individuals, Nature, 559, 400, 10.1038/s41586-018-0317-6 Shenolikar, 2018, Incidence of secondary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients with ovarian or breast cancer in a real-world setting in the United States, Gynecol Oncol, 151, 190, 10.1016/j.ygyno.2018.09.003 Sandner, 2019, Frequency of hematologic and solid malignancies in the family history of 50 patients with acute myeloid leukemia - a single center analysis, PLoS One, 14, 10.1371/journal.pone.0215453 Primon, 2019, Kinase regulation of HOX transcription factors, Cancers (Basel), 11, 508, 10.3390/cancers11040508 Bisaillon, 2011, C-terminal domain of MEIS1 converts PKNOX1 (PREP1) into a HOXA9-collaborating oncoprotein, Blood, 118, 4682, 10.1182/blood-2011-05-354076 Wu, 2019, HOXA5 inhibits tumor growth of gastric cancer under the regulation of microRNA-196a, Gene, 681, 62, 10.1016/j.gene.2018.09.051 Cimino, 2018, Increased HOXA5 expression provides a selective advantage for gain of whole chromosome 7 in IDH wild-type glioblastoma, Genes Dev, 32, 512, 10.1101/gad.312157.118 Zhang, 2017, Knockdown of HOXA5 inhibits the tumorigenesis in esophageal squamous cell cancer, Biomed Pharmacother, 86, 149, 10.1016/j.biopha.2016.12.012 Kettyle, 2019, Pathways, processes, and candidate drugs associated with a Hoxa cluster-dependency model of leukemia, Cancers (Basel), 11, 2036, 10.3390/cancers11122036 Li, 2015, Knockdown of homeobox A5 by small hairpin RNA inhibits proliferation and enhances cytarabine chemosensitivity of acute myeloid leukemia cells, Mol Med Rep, 12, 6861, 10.3892/mmr.2015.4331 Wei, 2017, Chinese guidelines for diagnosis and treatment of adult myeloid leukemia (Not APL) (2017), Chin J Hematol., 38, 177 Dohner, 2017, Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel, Blood, 129, 424, 10.1182/blood-2016-08-733196 Haferlach, 2010, Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group, J Clin Oncol, 28, 2529, 10.1200/JCO.2009.23.4732 Stegmaier, 2004, Gene expression-based high-throughput screening (GE-HTS) and application to leukemia differentiation, Nat Genet, 36, 257, 10.1038/ng1305 Canaani, 2017, Impact of FAB classification on predicting outcome in acute myeloid leukemia, not otherwise specified, patients undergoing allogeneic stem cell transplantation in CR1: an analysis of 1690 patients from the acute leukemia working party of EBMT, Am J Hematol, 92, 344, 10.1002/ajh.24640 Valk, 2004, Prognostically useful gene-expression profiles in acute myeloid leukemia, N Engl J Med, 350, 1617, 10.1056/NEJMoa040465 Wouters, 2009, Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome, Blood, 113, 3088, 10.1182/blood-2008-09-179895 Metzeler, 2008, An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia, Blood, 112, 4193, 10.1182/blood-2008-02-134411 Raponi, 2008, A 2-gene classifier for predicting response to the famesyltransferase inhibitor tipifarnib in acute myeloid leukemia, Blood, 111, 2589, 10.1182/blood-2007-09-112730 Heuser, 2005, Gene-expression profiles and their association with drug resistance in adult acute myeloid leukemia, Haematologica- Hematol J, 90, 1484 Blasi, 2017, A tale of TALE, PREP1, PBX1, and MEIS1: interconnections and competition in cancer, Bioessays, 39, 10.1002/bies.201600245 Merabet, 2016, To be specific or not: the critical relationship between Hox and TALE proteins, Trends Genet, 32, 334, 10.1016/j.tig.2016.03.004 Yuan, 2013, An unexpected switch: regulation of cardiomyocyte proliferation by the Homeobox gene Meis1, Circ Res, 113, 245, 10.1161/CIRCRESAHA.113.302023 Nagy, 2019, Elevated HOX gene expression in acute myeloid leukemia is associated with NPM1 mutations and poor survival, J Adv Res, 20, 105, 10.1016/j.jare.2019.05.006 Reedijk, 2019, Improved survival for children and young adolescents with acute myeloid leukemia: a Dutch study on incidence, survival and mortality, Leukemia, 33, 1349, 10.1038/s41375-018-0314-7 Creutzig, 2012, Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel, Blood, 120, 3187, 10.1182/blood-2012-03-362608 Karlsson, 2017, Outcome after intensive reinduction therapy and allogeneic stem cell transplant in paediatric relapsed acute myeloid leukaemia, Br J Haematol, 178, 592, 10.1111/bjh.14720 Yilmaz, 2019, Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?, Blood Cancer J, 9, 7, 10.1038/s41408-019-0170-3 Zhao, 2015, Aberrant expression of HOXA5 and HOXA9 in AML, Asian Pac J Cancer Prev, 16, 3941, 10.7314/APJCP.2015.16.9.3941 Kim, 2010, Level of HOXA5 hypermethylation in acute myeloid leukemia is associated with short-term outcome, Korean J Lab Med, 30, 469 Klein, 2017, Clinical and prognostic significance of eosinophilia and inv(16)/t(16;16) in pediatric acute myelomonocytic leukemia (AML-M4), Pediatr Blood Cancer, 64, e26512, 10.1002/pbc.26512 Desai, 2018, Somatic mutations precede myeloid leukemia years before diagnosis, Nat Med, 24, 1015, 10.1038/s41591-018-0081-z Gough, 2011, NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights, Blood, 118, 6247, 10.1182/blood-2011-07-328880 Okada, 2006, Leukaemic transformation by CALM-AF10 involves upregulation of Hoxa5 by hDOT1L, Nat Cell Biol, 8, 1017, 10.1038/ncb1464 Conway, 2015, A critical role for CRM1 in regulating HOXA gene transcription in CALM-AF10 leukemias, Leukemia, 29, 423, 10.1038/leu.2014.221 da Silva, 2019, HOXA cluster gene expression during osteoblast differentiation involves epigenetic control, Bone, 125, 74, 10.1016/j.bone.2019.04.026 Strathdee, 2007, HOXA5 is targeted by cell-type-specific CpG island methylation in normal cells and during the development of acute myeloid leukaemia, Carcinogenesis, 28, 299, 10.1093/carcin/bgl133 Kuhn, 2016, Targeting chromatin regulators inhibits leukemogenic gene expression in NPM1 mutant leukemia, Cancer Discovery, 6, 1166, 10.1158/2159-8290.CD-16-0237 Musialik, 2015, Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia, Mol Med Rep, 11, 3948, 10.3892/mmr.2015.3196 Brunetti, 2018, Mutant NPM1 maintains the leukemic state through HOX expression, Cancer Cell, 34, 499, 10.1016/j.ccell.2018.08.005 Ghasemi R, Struthers H, Wilson ER, Spencer DH. Contribution of CTCF binding to transcriptional activity at the HOXA locus in NPM1-mutant AML cells. Leukemia. Bach, 2010, Leukemogenic transformation by HOXA cluster genes, Blood, 115, 2910, 10.1182/blood-2009-04-216606 Zhang, 2018, Inactivation of PBX3 and HOXA9 by down-regulating H3K79 methylation represses NPM1-mutated leukemic cell survival, Theranostics, 8, 4359, 10.7150/thno.26900 Heath, 2017, Biological and clinical consequences of NPM1 mutations in AML, Leukemia, 31, 798, 10.1038/leu.2017.30 Daver, 2019, Targeting FLT3 mutations in AML: review of current knowledge and evidence, Leukemia, 33, 299, 10.1038/s41375-018-0357-9 Moore, 2007, Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells, Exp Hematol, 35, 105, 10.1016/j.exphem.2007.01.018 Gwin, 2010, Hoxa9 regulates Flt3 in lymphohematopoietic progenitors, J Immunol, 185, 6572, 10.4049/jimmunol.0904203 Skvarova Kramarzova, 2014, Homeobox gene expression in acute myeloid leukemia is linked to typical underlying molecular aberrations, J Hematol Oncol, 7, 94, 10.1186/s13045-014-0094-0